enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Women turn to weight loss drugs in menopause: What to know ...

   www.aol.com/women-turn-weight-loss-drugs...

   Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, according to Shepherd. The average age for menopause, when your periods stop ...

3. What Are GLP-1 Medications & Who Should Use Them? Here ... - AOL

   www.aol.com/glp-1-medications-them-heres...

   GLP-1 agonists are a class of medications that mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which is involved in insulin production and appetite regulation. “GLP-1 stands for ...

4. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 receptor agonist. Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, [1] are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1 that is released by the gut after ...

5. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

6. Women Are Losing More Weight on Ozempic—Scientists Are ...

   www.aol.com/lifestyle/women-losing-more-weight...

   Medications that can help you lose weight—like Wegovy and Ozempic—have become household names. But a new study found that the results may not look the same for everyone. The study, which was ...

7. 5-HT2C receptor agonist - Wikipedia

   en.wikipedia.org/wiki/5-HT2c_receptor_agonist

   The development of 5-HT 2C receptor knockout mice in the mid-1990s was a hallmark achievement in the identification and development of serotonergic drugs for weight loss. These knockout mice were hyperphagic , which led to obesity, partial Leptin resistance, increased adipose deposition, insulin resistance, and impaired glucose tolerance.